Dissemin is shutting down on January 1st, 2025

Published in

SAGE Publications, Journal of Child Neurology, 4(29), p. 538-544, 2013

DOI: 10.1177/0883073812474345

Links

Tools

Export citation

Search in Google Scholar

Mid-hindbrain Malformations Due to Drugs Taken During Pregnancy

Journal article published in 2013 by Laura Merlini, Joël Fluss, Amira Dhouib, Maria I. Vargas ORCID, Minerva Becker
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Although genetic defects are the leading cause of central nervous system malformations including in the posterior fossa, specific malformative patterns should alert the clinician to consider rather a teratogenic etiology. We discuss the imaging features of 2 mid-hindbrain malformations consecutive to the intake of isotretinoin (Roaccuatane®; case 1) and misoprostol (Cytotec®; case 2) during pregnancy and review the pertinent literature. We correlate the morphological appearance of the mid-hindbrain malformation, as seen on high-resolution magnetic resonance imaging to possible drug-induced pathogenetical mechanisms. The recognition of characteristic imaging patterns enables diagnosis of and/or confirmation of suspected drug-induced hindbrain malformations. This has important medicolegal implications and also clinical significance to avoid unsuccessful and misleading genetic testing.